InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: namtae post# 222396

Thursday, 08/18/2016 3:56:36 PM

Thursday, August 18, 2016 3:56:36 PM

Post# of 403204

Its possible the FDA changed all their criteria at the last moment and cost Elite an FDA approval for Sequest.

Any effective way to research this??


Sure thing - when it comes to ELTP DD there is no better in the business.

So let me help you out.

The FDA did in fact change their criteria as Nasrat stated it did. All one needs to do is read this 2002 FDA guidance document to verify this fact.

http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM126833.pdf

But while I'm at let's add another piece of FDA research that cannot be denied. In essence, Nasrat has stated he will refile SequestOx's submission and he knows his chances of SequestOx's approval move to 74.6%.

The total approval rate jumped nearly 20% to 74.6% after companies submitted responses to the US Food and Drug Administration's (FDA) CRLs. A third round of responses brought that percentage up an additional 8.3% to 82.9%.

- See more at: http://www.raps.org/focus-online/news/news-article-view/article/1138/bio-analysis-resubmissions-after-third-round-of-fda-review-not-worth-the-effort.aspx#sthash.fZk9osaF.dpuf


Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News